Business
INNOVATE Corp. Announces First Quarter 2025 Results
- Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) System Received FDA Approval to Assess Kidney Function -- Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the first quarter. Financial Summary (in millions, except per share a
About this update from Innovate Corp.
[{"type":"image","alt":"INNOVATE Corp.","displaySize":"","headline":null,"caption":"INNOVATE Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":155,"url":"https://media.zenfs.com/en/globenewswire.com/f6839c69bcfd01d6eebbc83e70475620"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/HRT7VOVi6Bwl5KlGPoGQeg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f6839c69bcfd01d6eebbc83e70475620","width":300,"height":155}},"lazy":false},{"type":"text","content":"- Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) System Received FDA Approval to Assess Kidney Function -- Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - ","length":286,"tagName":"p"},{"type":"text","content":"NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the first quarter.","length":164,"tagName":"p"},{"type":"text","content":"Financial Summary","length":17,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"text-align:left;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"(in millions, except per share amounts)","length":39,"tagName":"p","attribs":{}}]},{"colspan":"10","style":"border-top:solid black 1pt;border-bottom:solid black 1pt;text-align:center;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Three Months Ended March 31,","length":28,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"border-bottom:solid black 1pt;padding-right:0;text-align:right;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"border-bottom:solid black 1pt;padding-left:0;padding-right:0;text-align:center;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":"2025","length":4,"tagName":"p","attribs":{}}]},{"style":"border-bottom:solid black 1pt;padding-left:0;text-align:left;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"bor...